Amryt Pharma plc reaffirmed revenue guidance for fiscal year 2022. For the year, the company is reaffirming revenue guidance for fiscal year 2022 in the range of $260 million - $270 million which represents growth of 17% to 21% on fiscal year 2021.
1st Jan change | Capi. | |
---|---|---|
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |